229 related articles for article (PubMed ID: 24718382)
1. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
[TBL] [Abstract][Full Text] [Related]
2. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; Marwick TH
Heart; 2013 Mar; 99(5):320-6. PubMed ID: 23343682
[TBL] [Abstract][Full Text] [Related]
4. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction.
Kosmala W; Przewlocka-Kosmala M; Wojnalowicz A; Mysiak A; Marwick TH
Eur Heart J Cardiovasc Imaging; 2012 Jun; 13(6):459-67. PubMed ID: 22185752
[TBL] [Abstract][Full Text] [Related]
5. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
[TBL] [Abstract][Full Text] [Related]
6. The PPARGC1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men.
Ingelsson E; Bennet L; Ridderstråle M; Söderström M; Råstam L; Lindblad U
BMC Cardiovasc Disord; 2008 Dec; 8():37. PubMed ID: 19077249
[TBL] [Abstract][Full Text] [Related]
7. Target organ status in white-coat hypertensives: usefulness of serum procollagen type I propeptide in the respect of left ventricular diastolic dysfunction.
Ihm SH; Youn HJ; Park CS; Kim HY; Chang K; Seung KB; Kim JH; Choi KB
Circ J; 2009 Jan; 73(1):100-5. PubMed ID: 19023153
[TBL] [Abstract][Full Text] [Related]
8. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of Parameters of Transmitral Blood Flow and Markers of Myocardial Fibrosis in Patients with Myocardial Infarction].
Osokina AV; Karetnikova VN; Polikutina OM; Ivanova AV; Artemova TP; Ryzhenkova SN; Avramenko OE; Gruzdeva OV; Barbarash OL
Kardiologiia; 2020 Jul; 60(6):994. PubMed ID: 32720621
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot.
Lai CT; Chan KW; Wong SJ; Chow PC; Cheung YF
Am Heart J; 2011 Sep; 162(3):467-73. PubMed ID: 21884862
[TBL] [Abstract][Full Text] [Related]
12. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
[TBL] [Abstract][Full Text] [Related]
13. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
14. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.
Lee CH; Lee WC; Chang SH; Wen MS; Hung KC
PLoS One; 2015; 10(1):e114097. PubMed ID: 25559610
[TBL] [Abstract][Full Text] [Related]
16. Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.
Su CT; Liu YW; Lin JW; Chen SI; Yang CS; Chen JH; Hung KY; Tsai WC; Huang JW
J Am Soc Echocardiogr; 2012 Aug; 25(8):895-901. PubMed ID: 22658561
[TBL] [Abstract][Full Text] [Related]
17. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
Clin Exp Hypertens; 2015; 37(2):155-65. PubMed ID: 25050647
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
19. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
Gupta A; Schiros CG; Gaddam KK; Aban I; Denney TS; Lloyd SG; Oparil S; Dell'Italia LJ; Calhoun DA; Gupta H
J Hum Hypertens; 2015 Apr; 29(4):241-6. PubMed ID: 25231508
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
